Lv31
240 积分 2024-07-04 加入
Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China
29天前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
1个月前
已完结
Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study
2个月前
已完结
[Perioperative immunotherapy for non-small cell lung cancer: consensus and controversy (2024 edition)]
2个月前
已完结
Large-Cell Neuroendocrine Carcinoma of the Lung Harboring EGFR Mutation and Responding to Gefitinib
2个月前
已完结
Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS)
2个月前
已完结
The Proposed 9th Edition TNM Classification of Lung Cancer
2个月前
已完结
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer
2个月前
已完结
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
3个月前
已完结
皖公网安备34019202002308
